edison tv
Investment Companies
“Edison is the go-to for a new investor to get full understanding of the investment case and business. Edison’s distribution reaches investors that we want to connect with directly.”
Associated equity: Biodexa Pharmaceuticals
Edison Investment Research is terminating coverage on Biodexa Pharmaceuticals (BDRX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.
Biodexa Pharmaceuticals — 2 videos in collection
Midatech Pharma: is a drug-delivery specialist focused on re-engineering therapeutics through its technology platforms (MidaSolve – local drug-delivery, Qsphera – sustained-release, MidaCore – targeted delivery) to improve their bioavailability and delivery.
• Tell us about your drug delivery technology and why it’s necessary?
• How are your three different technology platforms: Q-Sphera, MidaSolve and MidaCore different from other drug delivery solutions?
• What advantages does Midatech offer over others in this space?
• What is the pipeline for Q-Sphera?
• How can your technology be used to enhance existing medicines?
• What can you tell us about your other key programme, MTX110?
• What are your commercialisation plans for MTX110?
• Which milestones should investors focus on in the coming year?
• How do you see the opportunities for partnerships and licensing opportunities developing?
• What does your cash runway look like?
Get access to the very latest content matched to your personal investment style.